ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
27 announcements with these filters
Deep Health AI India Limited has announced the resignation of Mr. Rajesh Nandkishore Pherwani as a Non-Executive Independent Director, effective September 11, 2026.
Deep Health AI India sent a Reg 36(1)(b) letter to shareholders with unregistered emails, providing the Annual Report FY25-26 weblink and AGM e-voting details. No financial or business substance is disclosed.
Deep Health AI India Limited has released its 32nd Annual Report for the financial year 2025-2026, including the notice of its upcoming Annual General Meeting.
Deep Health AI India Limited has issued the notice for its 32nd Annual General Meeting scheduled for September 30, 2026. The agenda includes financial statement adoption.
Deep Health AI India Limited has appointed Mr. Virendra Choubisa as an Independent Director and M/s Vimal C Surana and Company as the new Statutory Auditor.
Deep Health AI India Limited held its board meeting, approving the 32nd AGM, a new director appointment, and a new statutory auditor appointment.
Deep Health AI India Ltd reported revenue from operations of ₹0.5 Cr (+400.0% YoY) and a net loss of ₹2.1 Cr for Q1 FY27.
Deep Health AI India Ltd has scheduled a Board Meeting on August 13, 2026, to consider and approve its un-audited standalone and consolidated financial results.
Deep Health AI India Limited announced the appointment of Mr. Bhupesh Swami and Mrs. Shashi Kala Dhabriya as Non-Executive Independent Directors on the Board.
Deep Health AI India held its 1st Extra-Ordinary General Meeting on July 30, 2026. Shareholders passed all resolutions, including the appointment of two independent directors.
Deep Health AI India entered an MoU to acquire 49,100 sq. mtr. of land in Pune. The company paid a Rs. 2.85 Crore advance.
Deep Health AI India submitted a revised Auditor's Report for FY26 to include previously omitted entity names. The correction has no financial impact.
Deep Health AI India Ltd. will hold an EGM on July 30, 2026, for shareholder approvals. E-voting opens July 27, 2026, for members on record as of July 23, 2026.
Deep Health AI India Ltd board approved calling an EGM on July 30, 2026. The meeting was held via video conferencing on July 2, 2026.
Deep Health AI India appointed Mr. Bhupesh Swami as an Additional Independent Director. His term runs for two years from July 2, 2026.
Deep Health AI acquired a 6.37% stake in Leapfrog Engineering Services Ltd. The acquisition cost was ₹19.92 Crore.
Deep Health AI India approved audited financial results for FY26. The company also appointed M/s. Valawat & Associates as Internal Auditors for the 2026-2027 fiscal year.
Deep Health AI India Ltd reported revenue from operations of ₹0.2 Cr (-60.0% YoY) and a net loss of ₹4.5 Cr for Q4 FY26.
Deep Health AI India Limited reported FY26 total income of ₹8.49 Crore. The board also approved appointing M/s. Valawat & Associates as internal auditors for FY27.
Deep Health AI India Ltd fully utilized ₹39.98 Crore raised via a Rights Issue. Proceeds were primarily diverted to equity investments in other companies.
Deep Health AI India Limited filed its FY 2026 Annual Secretarial Compliance Report. The report notes a ₹7,080 fine for a minor procedural filing delay.
Deep Health AI India Limited deferred its board meeting to May 29, 2026. The postponement allows management to seek further clarifications regarding audited financial results.
Deep Health AI India Limited scheduled a May 27 board meeting to approve audited FY26 financial results. Trading window remains closed for designated persons.
Deep Health AI India Limited has approved a fundraise of up to ₹25 Crore through a rights issue of equity shares. The Board constituted a Rights Issue Committee to determine the final terms, including the entitlement ratio and record date. The proceeds will strengthen the company's capital base.
Deep Health AI India Ltd has scheduled a Board Meeting on May 04, 2026, to consider raising funds via a Rights Issue of Equity Shares. The company also noted its trading window remains closed until 48 hours after the declaration of audited financial results for the year ended March 31, 2026.
Deep Health AI India Limited has shifted its Registered Office from Mumbai, Maharashtra to Udaipur, Rajasthan. The change follows approval from the Ministry of Corporate Affairs and has resulted in a new CIN: L24100RJ1994PLC112895. The company's Memorandum of Association has been amended to reflect this change in jurisdiction to ROC Jaipur.
Mr. Kailash Chandra has resigned as an Independent Director of Deep Health AI India Limited, effective April 03, 2026. The resignation is attributed to personal reasons, with no other material concerns reported. He also ceased to be a member of the Audit, Nomination & Remuneration, and Stakeholders Relationship Committees.